| Year |
Citation |
Score |
| 2022 |
Lahman MC, Schmitt TM, Paulson KG, Vigneron N, Buenrostro D, Wagener FD, Voillet V, Martin L, Gottardo R, Bielas J, McElrath JM, Stirewalt DL, Pogosova-Agadjanyan EL, Yeung CC, Pierce RH, ... ... McAfee MS, et al. Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency. Science Translational Medicine. 14: eabg8070. PMID 35138909 DOI: 10.1126/scitranslmed.abg8070 |
0.61 |
|
| 2020 |
Wright JH, Huang LY, Weaver S, Archila LD, McAfee MS, Hirayama AV, Chapuis AG, Bleakley M, Rongvaux A, Turtle CJ, Chanthaphavong S, Campbell JS, Pierce RH. Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistry. Journal of Immunological Methods. 112955. PMID 33383062 DOI: 10.1016/j.jim.2020.112955 |
0.347 |
|
| 2020 |
Ecsedi M, McAfee MS, Chapuis AG. The Anticancer Potential of T Cell Receptor-Engineered T Cells. Trends in Cancer. PMID 32988787 DOI: 10.1016/j.trecan.2020.09.002 |
0.348 |
|
| 2019 |
Chapuis AG, Egan DN, Bar M, Schmitt TM, McAfee MS, Paulson KG, Voillet V, Gottardo R, Ragnarsson GB, Bleakley M, Yeung CC, Muhlhauser P, Nguyen HN, Kropp LA, Castelli L, et al. T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant. Nature Medicine. PMID 31235963 DOI: 10.1038/S41591-019-0472-9 |
0.558 |
|
| 2018 |
Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N, Thomas H, Colunga AG, Iyer JG, Yee C, Kulikauskas R, et al. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nature Communications. 9: 3868. PMID 30250229 DOI: 10.1038/S41467-018-06300-3 |
0.575 |
|
| 2017 |
Paulson KG, Perdicchio M, Kulikauskas R, Wagener F, Church C, Bui K, Vandeven N, Thomas H, McAfee M, Miller N, Chin KM, Su Z, Greenberg PD, Parvathaneni U, Bhatia S, et al. Augmentation of adoptive T-cell therapy for Merkel cell carcinoma with avelumab. Journal of Clinical Oncology. 35: 3044-3044. DOI: 10.1200/Jco.2017.35.15_Suppl.3044 |
0.651 |
|
| 2016 |
Holechek SA, McAfee MS, Nieves LM, Guzman VP, Manhas K, Fouts T, Bagley K, Blattman JN. Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination. Vaccine. PMID 27670072 DOI: 10.1016/J.Vaccine.2016.09.013 |
0.663 |
|
| 2016 |
Chapuis A, Egan DN, Bar M, Schmitt TM, McAfee M, Perdicchio M, Ragnarsson GB, Yeung CC, Nguyen H, Kropp L, Castelli L, Wagener F, Hunter D, Cohen K, Seese A, et al. EBV-Specific Donor Cells Transduced to Express a High-Affinity WT1 TCR Can Prevent Recurrence in Post-HCT Patients with High-Risk AML Blood. 128: 1001-1001. DOI: 10.1182/Blood.V128.22.1001.1001 |
0.547 |
|
| 2015 |
McAfee MS, Huynh TP, Johnson JL, Jacobs BL, Blattman JN. Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity. Virology. 484: 153-162. PMID 26099694 DOI: 10.1016/J.Virol.2015.05.021 |
0.628 |
|
| 2015 |
Lussier DM, O'Neill L, Nieves LM, McAfee MS, Holechek SA, Collins AW, Dickman P, Jacobsen J, Hingorani P, Blattman JN. Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions. Journal of Immunotherapy (Hagerstown, Md. : 1997). 38: 96-106. PMID 25751499 DOI: 10.1097/Cji.0000000000000065 |
0.668 |
|
| 2013 |
Lussier DM, Nieves LM, McAfee MS, Hyunh TP, Holechek SA, Hingorani P, Blattman JN. Enhancement of T cell immunity to osteosarcoma through modulation of PD-1/PD-L1 interactions Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P162 |
0.671 |
|
| 2012 |
Stromnes IM, Fowler C, Casamina CC, Georgopolos CM, McAfee MS, Schmitt TM, Tan X, Kim TD, Choi I, Blattman JN, Greenberg PD. Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo. Journal of Immunology (Baltimore, Md. : 1950). 189: 1812-25. PMID 22798667 DOI: 10.4049/Jimmunol.1200552 |
0.725 |
|
| 2012 |
McAfee MS, Blattman JN. Combating chronic T-cell exhaustion. Immunotherapy. 4: 557-60. PMID 22788120 DOI: 10.2217/Imt.12.46 |
0.708 |
|
| 2011 |
Johnson PL, Kochin BF, McAfee MS, Stromnes IM, Regoes RR, Ahmed R, Blattman JN, Antia R. Vaccination alters the balance between protective immunity, exhaustion, escape, and death in chronic infections. Journal of Virology. 85: 5565-70. PMID 21411537 DOI: 10.1128/Jvi.00166-11 |
0.695 |
|
| Show low-probability matches. |